Allegheny Financial Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,065
Closed -$66K 314
2026
Q1
$66K Hold
17,065
0.01% 286
2025
Q4
$71.3K Hold
17,065
0.01% 284
2025
Q3
$56.1K Sell
17,065
-37,065
-68% -$105K 0.01% 260
2025
Q2
$76.9K Hold
54,130
0.02% 244
2025
Q1
$80.7K Hold
54,130
0.02% 225
2024
Q4
$60.6K Buy
+54,130
New +$46.2K 0.02% 225

Other funds holding PGEN

Allegheny Financial Group's PGEN Position: Q2 2026 in Review

Allegheny Financial Group sold out of Precigen (PGEN) in Q2 2026, closing a stake of 17,065 shares — an estimated $66K sold.

Allegheny Financial Group first reported a position in PGEN in Q4 2024 and held it in 6 quarters. The position peaked at $80.7K in Q1 2025. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Allegheny Financial Group reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
  • Allegheny Financial Group sold 17,065 Precigen shares in Q2 2026, an estimated $66K.
  • Allegheny Financial Group first reported a position in Precigen in Q4 2024 and held it in 6 quarters.
  • Allegheny Financial Group's Precigen position peaked at $80.7K in Q1 2025.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Allegheny Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.